These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 12887389)

  • 1. Evidence for antinociceptive activity of botulinum toxin type A in pain management.
    Aoki KR
    Headache; 2003; 43 Suppl 1():S9-15. PubMed ID: 12887389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes].
    Göbel H; Heinze A; Heinze-Kuhn K; Austermann K
    Nervenarzt; 2001 Apr; 72(4):261-74. PubMed ID: 11320861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
    Dodick DW
    Headache; 2003; 43 Suppl 1():S25-33. PubMed ID: 12887391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum neurotoxin A for chronic migraine headaches: does it work and how?
    Cairns BE; Gazerani P
    Pain Manag; 2014; 4(6):377-80. PubMed ID: 25494688
    [No Abstract]   [Full Text] [Related]  

  • 5. [Potential antinociceptive mechanisms of botulinum toxin].
    Aoki KR; Francis J; Jost WH
    Schmerz; 2006 Sep; 20(5):381-2, 384-7. PubMed ID: 16819667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region.
    Drinovac Vlah V; Filipović B; Bach-Rojecky L; Lacković Z
    Eur J Pain; 2018 Mar; 22(3):583-591. PubMed ID: 29134730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin--a treatment for migraine? A systematic review.
    Gupta VK
    Pain Med; 2006; 7(5):386-94. PubMed ID: 17014596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin in pain treatment.
    Colhado OC; Boeing M; Ortega LB
    Rev Bras Anestesiol; 2009; 59(3):366-81. PubMed ID: 19488551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Applications of botulinum toxin in Neurology].
    Garcia-Ruiz PJ
    Med Clin (Barc); 2013 Jul; 141(1):33-6. PubMed ID: 23434466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin: A review of the mode of action in migraine.
    Do TP; Hvedstrup J; Schytz HW
    Acta Neurol Scand; 2018 May; 137(5):442-451. PubMed ID: 29405250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin for the treatment of musculoskeletal pain and spasm.
    Sheean G
    Curr Pain Headache Rep; 2002 Dec; 6(6):460-9. PubMed ID: 12413405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of botulinum toxin type A in pain medicine].
    Schwarzer A; Mäcken T; Enax-Krumova EK
    Schmerz; 2023 Aug; 37(4):297-307. PubMed ID: 37365293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
    Zhang X; Strassman AM; Novack V; Brin MF; Burstein R
    Cephalalgia; 2016 Aug; 36(9):875-86. PubMed ID: 26984967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
    Durham PL; Cady R; Cady R
    Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats.
    Melo-Carrillo A; Strassman AM; Schain AJ; Noseda R; Ashina S; Adams A; Brin MF; Burstein R
    Cephalalgia; 2019 Oct; 39(11):1358-1365. PubMed ID: 31475573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure and mode of action of different botulinum toxins.
    Dolly JO; Aoki KR
    Eur J Neurol; 2006 Dec; 13 Suppl 4():1-9. PubMed ID: 17112344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.
    Cui M; Khanijou S; Rubino J; Aoki KR
    Pain; 2004 Jan; 107(1-2):125-33. PubMed ID: 14715398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on the antinociceptive mechanism hypothesis of botulinum toxin A.
    Aoki KR; Francis J
    Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S28-33. PubMed ID: 21999893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A, brain and pain.
    Matak I; Lacković Z
    Prog Neurobiol; 2014; 119-120():39-59. PubMed ID: 24915026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of botulinum toxin type A and its clinical applications in migraine headache.
    Silberstein SD
    Expert Opin Pharmacother; 2001 Oct; 2(10):1649-54. PubMed ID: 11825307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.